Healthy adults
Conditions
Interventions
Duration: 12 weeks Test materials: Sea squirt-derived plasmalogen capsule Dose: 1 capsule, once a day Administration: Take 1 capsule per day any time during the day
Duration: 12 weeks Test mater
Sponsors
ORTHOMEDICO Inc.
Seishin-kai Medical Association Inc, Takara Medical Clinic
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Healthy Japanese adults who feel memory loss 2. Those who are not dementia and are considered as appropriate for the study by the physician 3. Those who get 24 or more in score of MMSE 4. Those who have lower score in total score of Cognitrax
Exclusion criteria
Exclusion criteria: 1. At least one previous medical history of malignant tumor, heart failure or myocardial infarction 2. Currently under the treatment for either cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension or other chronic diseases 3. Those who have dementia 4. Those who have depression disorder, ADHD, or etc. such as mental illness 5. Those who use or take "Foods for Specified Health Uses" and "Foods with Functional Claims" in daily 6. Currently taking medicines and/or herbal medicines 7. Those who take DHA or/and EPA-containing food in daily 8. Those who are allergic to medicines and/or the test food related products 9. Those who are pregnant, breast-feeding, and plan to become a pregnant 10. Those who had participated another clinical test for three months when you signed the informed consent form for this trial 11. Others considered as inappropriate for the study by the physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Neuropsychological tests (Cognitrax) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Dementia Assessment Sheet in Community-based Integrated Care System (DASC-21) 2. Original questionnaire (Likert scale) | — |
Countries
Japan
Contacts
Public ContactNaoko SUZUKI
ORTHOMEDICO Inc. R&D Department
Outcome results
None listed